全文获取类型
收费全文 | 8523篇 |
免费 | 989篇 |
国内免费 | 5篇 |
出版年
2023年 | 28篇 |
2022年 | 46篇 |
2021年 | 139篇 |
2020年 | 75篇 |
2019年 | 97篇 |
2018年 | 83篇 |
2017年 | 93篇 |
2016年 | 182篇 |
2015年 | 345篇 |
2014年 | 382篇 |
2013年 | 431篇 |
2012年 | 608篇 |
2011年 | 635篇 |
2010年 | 350篇 |
2009年 | 334篇 |
2008年 | 495篇 |
2007年 | 512篇 |
2006年 | 509篇 |
2005年 | 509篇 |
2004年 | 479篇 |
2003年 | 483篇 |
2002年 | 439篇 |
2001年 | 125篇 |
2000年 | 106篇 |
1999年 | 143篇 |
1998年 | 132篇 |
1997年 | 103篇 |
1996年 | 94篇 |
1995年 | 82篇 |
1994年 | 90篇 |
1993年 | 80篇 |
1992年 | 74篇 |
1991年 | 83篇 |
1990年 | 54篇 |
1989年 | 64篇 |
1988年 | 65篇 |
1987年 | 76篇 |
1986年 | 65篇 |
1985年 | 70篇 |
1984年 | 76篇 |
1983年 | 65篇 |
1982年 | 88篇 |
1981年 | 56篇 |
1980年 | 62篇 |
1979年 | 48篇 |
1978年 | 41篇 |
1977年 | 44篇 |
1976年 | 33篇 |
1975年 | 35篇 |
1974年 | 24篇 |
排序方式: 共有9517条查询结果,搜索用时 15 毫秒
1.
2.
Modulation of the expression of interleukin 2 receptors of human thymocytes by recombinant interleukin 2 总被引:3,自引:0,他引:3
The effect of purified recombinant interleukin 2 on the expression of the receptors for interleukin 2 by human thymocytes was examined. Interleukin 2 augmented the expression of interleukin 2 receptors and interferon-gamma synthesis by thymocytes activated with concanavalin A, and it was required to maintain the growth of thymocytes in vitro and the expression of interleukin 2 receptors. The increase observed in the number of receptor bearing thymocytes and in the density of receptors due to interleukin 2 occurred within the first 2 days of culture. Dexamethasone inhibited the expression of interleukin 2 receptors, the synthesis of interferon-gamma, and the early proliferation and protein synthesis of lectin-activated thymocytes during the first 2 days of culture. The inhibitory effect of dexamethasone on the expression of interleukin 2 receptors and on the synthesis of interferon-gamma was reversed by interleukin 2, whereas its effect on proliferation and on protein synthesis during the first two days of culture was not reversed by interleukin 2. Interleukin 2 induced the proliferation of thymocytes in vitro, even in the absence of activation by lectin; however, the number of cells displaying receptors which could be detected with anti-Tac remained low throughout the first week of culture and interferon-gamma synthesis was not observed. Nonetheless, interleukin 2-induced proliferation was inhibited by anti-Tac on a dose dependent manner. The results of the study document that recombinant interleukin 2, like purified natural interleukin 2, is required for the expression of interleukin 2 receptors, for interferon-gamma synthesis, and for the growth of thymocytes in vitro. 相似文献
3.
4.
5.
A group of captive chimpanzees, consisting of one adult male and three mother/infant pairs, was systematically observed over a 15-month period. Over 200 hr of data were collected, using both sequential and time sampling techniques, and compared to the available data on wild chimps. Unlike many captive groups, most behavior patterns were remarkably similar, both qualitatively and quantitatively, to that of wild chimpanzees including: play, grooming, infant sexual development, tool use, food sharing, prosocial partner preferences, and aggressive displays. 相似文献
6.
7.
Nancy Burton Wurster George Lust 《Biochimica et Biophysica Acta (BBA)/General Subjects》1984,800(1):52-58
The content and the biosynthesis of fibronectin was examined in disease-free articular cartilage and in articular cartilage from osteoarthritic canine joints. Fibronectin content was increased in extracts of cartilage from osteoarthritic joints. Incubation of cartilage in vitro with [3H]phenylalanine and subsequent isolation of [3H]fibronectin from a gelatin affinity column and characterization by SDS-polyacrylamide gel electrophoresis and by immunoprecipitation indicated that disease-free and osteoarthritic cartilage explants synthesized fibronectin. About 50% of the [3H]fibronectin was recovered in the incubation medium. The osteoarthritic cartilage synthesized and accumulated up to 5-fold more [3H]fibronectin than disease-free cartilage. 相似文献
8.
Emily Olfson Catherine E. Cottrell Nicholas O. Davidson Christina A. Gurnett Jonathan W. Heusel Nathan O. Stitziel Li-Shiun Chen Sarah Hartz Rakesh Nagarajan Nancy L. Saccone Laura J. Bierut 《PloS one》2015,10(9)
The American College of Medical Genetics and Genomics (ACMG) recommends that clinical sequencing laboratories return secondary findings in 56 genes associated with medically actionable conditions. Our goal was to apply a systematic, stringent approach consistent with clinical standards to estimate the prevalence of pathogenic variants associated with such conditions using a diverse sequencing reference sample. Candidate variants in the 56 ACMG genes were selected from Phase 1 of the 1000 Genomes dataset, which contains sequencing information on 1,092 unrelated individuals from across the world. These variants were filtered using the Human Gene Mutation Database (HGMD) Professional version and defined parameters, appraised through literature review, and examined by a clinical laboratory specialist and expert physician. Over 70,000 genetic variants were extracted from the 56 genes, and filtering identified 237 variants annotated as disease causing by HGMD Professional. Literature review and expert evaluation determined that 7 of these variants were pathogenic or likely pathogenic. Furthermore, 5 additional truncating variants not listed as disease causing in HGMD Professional were identified as likely pathogenic. These 12 secondary findings are associated with diseases that could inform medical follow-up, including cancer predisposition syndromes, cardiac conditions, and familial hypercholesterolemia. The majority of the identified medically actionable findings were in individuals from the European (5/379) and Americas (4/181) ancestry groups, with fewer findings in Asian (2/286) and African (1/246) ancestry groups. Our results suggest that medically relevant secondary findings can be identified in approximately 1% (12/1092) of individuals in a diverse reference sample. As clinical sequencing laboratories continue to implement the ACMG recommendations, our results highlight that at least a small number of potentially important secondary findings can be selected for return. Our results also confirm that understudied populations will not reap proportionate benefits of genomic medicine, highlighting the need for continued research efforts on genetic diseases in these populations. 相似文献
9.
10.